Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diabetes Products Should Be Exempt From Competitive Bidding – Panel

This article was originally published in The Gray Sheet

Executive Summary

Supplier and manufacturer stakeholders are urging CMS to exclude blood glucose testing products from the impending DMEPOS competitive bidding program

You may also be interested in...



BD Exits Glucose Monitoring Market After Being “Eclipsed” By Competitors

Becton Dickinson is dropping out of the increasingly competitive blood glucose monitoring market, acknowledging that it has been too slow to innovate in a sector that generated about $105 mil. in BD sales for the 12 months ended Sept. 30

BD Exits Glucose Monitoring Market After Being “Eclipsed” By Competitors

Becton Dickinson is dropping out of the increasingly competitive blood glucose monitoring market, acknowledging that it has been too slow to innovate in a sector that generated about $105 mil. in BD sales for the 12 months ended Sept. 30

DMEPOS codes reviewed

CMS has made preliminary decisions regarding 112 requests for changes to HCPCS codes for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) in 2007. The agency will hear public comments on the decisions in a series of meetings from April 25 to May 5. During a Program Advisory & Oversight Committee meeting in September, DMEPOS stakeholders stressed the need to update and expand HCPCS codes for their products before competitive bidding is instituted in 2007. Without the update, suppliers under the system may hamper beneficiary access by providing the lowest quality products within each code, they warned (1"The Gray Sheet" Oct. 3, 2005, p. 15)...

Related Content

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel